Hutch News

Hutch News

Stories tagged 'ASCO 2018'

Fred Hutch at ASCO

Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering

June 5, 2018 | By Fred Hutch staff

Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering

View story >


Immunotherapy has long-term benefit for patients with advanced Merkel cell carcinoma

‘Incredibly big change’ in treatment of deadly skin cancer, new data show

June 4, 2018 | by Susan Keown / Fred Hutch News Service

Immunotherapy drugs have transformed the treatment of a deadly skin cancer, Merkel cell carcinoma. New trial results show these drugs help many patients survive much longer than would otherwise be possible.

View story >


At half the cost, Canadian colorectal cancer survival similar to U.S.

Cross-border collaboration compared findings in British Columbia and Washington state

June 1, 2018 | By Sabin Russell / Fred Hutch News Service

In a rare comparison of cancer care in neighboring regions of the U.S. and Canada, a new study found Americans were paying twice as much for similar colorectal cancer treatments, with no advantage in survival rates.

View story >


President's Cancer Panel addresses cost of cancer drugs

Fred Hutch leaders helped shape recommendations that put patients first, promoting value, affordability, innovation

March 12, 2018 | By Sabin Russell / Fred Hutch News Service

The President's Cancer Panel, an independent advisory group, called for “urgent action” to address rapidly rising prices for cancer drugs and the burden cancer patients and their families face because of the high cost of cancer care.

View story >


Surviving cancer without going broke

HICOR’s Value in Cancer Care Summit tackles skyrocketing costs, financial toxicity, balancing cost with the right care and more

April 11, 2017 | By Diane Mapes / Fred Hutch News Service

About 200 patients, payers, providers and policymakers gathered with Fred Hutch researchers April 7 to discuss ways to bump value and bring down costs of cancer care. The day-long event marked the fourth Value in Cancer Care Summit, sponsored by the Hutchinson Institute for Cancer Outcomes Research.

View story >


With immunotherapy trial, ‘a real paradigm shift’ in rare skin cancer

Investigators report ‘extraordinarily’ long-lasting treatment responses in patients with chemo-resistant, metastatic Merkel cell carcinoma

April 3, 2017 | By Susan Keown / Fred Hutch News Service

Investigators report ‘extraordinarily’ long-lasting treatment responses in patients with chemo-resistant, metastatic Merkel cell carcinoma.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.